131 related articles for article (PubMed ID: 2473787)
1. Pregnancy-associated plasma protein-A in pregnant cynomolgus monkeys (Macaca fascicularis): radioimmunoassay, normal levels, effect of RU 486, and preliminary characterization.
Bischof P; Germain G; Cedard L
Biol Reprod; 1989 Apr; 40(4):853-9. PubMed ID: 2473787
[TBL] [Abstract][Full Text] [Related]
2. Progesterone dependence and extratrophoblastic origin of pregnancy-associated plasma protein-A (PAPP-A) in early pregnancy.
Bischof P; Schindler AM; Wyss R; Herrmann WL; Sizonenko PC
Arch Gynecol; 1986; 237(3):109-16. PubMed ID: 2420291
[TBL] [Abstract][Full Text] [Related]
3. Trophoblastic and decidual response to RU486: effects on human chorionic gonadotrophin, human placental lactogen, prolactin and pregnancy-associated plasma protein-A production in vitro.
Bischof P; Sizonenko MT; Herrmann WL
Hum Reprod; 1986 Jan; 1(1):3-6. PubMed ID: 2458379
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
Olajide F; Howell RJ; Wass JA; Holly JM; Bohn H; Grudzinskas JG; Chapman MG; Chard T
Hum Reprod; 1989 Apr; 4(3):337-40. PubMed ID: 2715311
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of SP1-like immunoreactive material (SP1) and progesterone throughout pregnancy and following RU 486-induced early abortion in the cynomolgus monkey (Macaca fascicularis).
Germain G; Mignot T; Bischof P; Mouren M; Cédard L
Hum Reprod; 1989 Nov; 4(8):975-80. PubMed ID: 2693485
[TBL] [Abstract][Full Text] [Related]
6. Immunological heterogeneity of pregnancy-associated plasma protein-A (PAPP-A). Effects on the radioimmunoassay of PAPP-A.
Bischof P; Meisser A
Br J Obstet Gynaecol; 1989 Jul; 96(7):870-5. PubMed ID: 2475161
[TBL] [Abstract][Full Text] [Related]
7. Mifepristone commentary ignores abortion controversy.
Am J Hosp Pharm; 1989 Jul; 46(7):1344-6. PubMed ID: 2757039
[No Abstract] [Full Text] [Related]
8. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
[TBL] [Abstract][Full Text] [Related]
9. The disappearance rate of pregnancy-associated plasma protein-A (PAPP-A) after the end of normal and abnormal pregnancies.
Bischof P; Amandruz M; Weil-Franck C; Baeriswyl JP; Weil A; Hermann WL; Sizonenko PC
Arch Gynecol; 1984; 236(2):93-8. PubMed ID: 6084476
[TBL] [Abstract][Full Text] [Related]
10. [The antiprogesterone action of mifepristone].
Willems F
Ned Tijdschr Geneeskd; 1989 Jun; 133(22):1139-40. PubMed ID: 2739799
[No Abstract] [Full Text] [Related]
11. The effect of the anti-progestin RU 486 on early pregnancy in the long-tailed macaque (Macaca fascicularis).
Owiti GE; Tarantal AF; Lasley BL; Hendrickx AG
Contraception; 1989 Aug; 40(2):201-11. PubMed ID: 2758841
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy-associated plasma protein A in human ovarian follicular fluid.
Sinosich MJ; Porter R; Sloss P; Bonifacio MD; Saunders DM
J Clin Endocrinol Metab; 1984 Mar; 58(3):500-4. PubMed ID: 6198333
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy.
Urquhart DR; Bahzad C; Templeton AA
Hum Reprod; 1989 Feb; 4(2):202-3. PubMed ID: 2918074
[TBL] [Abstract][Full Text] [Related]
14. Contragestive effects of the antigestagenic agent, RU486, in rats and rabbits.
Tsujii T; Kambegawa A; Kobayashi M; Arakawa S; Okinaga S; Arai K
Asia Oceania J Obstet Gynaecol; 1989 Jun; 15(2):169-73. PubMed ID: 2757576
[TBL] [Abstract][Full Text] [Related]
15. Tissue and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A): comparison with other fetoplacental products.
Duberg S; Bischof P; Schindler AM; Béguin F; Herrmann W; Sizonenko PC
Br J Obstet Gynaecol; 1982 May; 89(5):352-7. PubMed ID: 6177336
[TBL] [Abstract][Full Text] [Related]
16. Binding of pregnancy-associated plasma protein-A (PAPP-A) to placental subfractions.
Isaka K; Bischof P
Arch Gynecol; 1986; 237(3):117-26. PubMed ID: 2420292
[TBL] [Abstract][Full Text] [Related]
17. RU 486 induced suppression of placental neutrophil elastase inhibitor levels.
Sinosich MJ; Lee J; Wolf JP; Williams RF; Hodgen GD
Placenta; 1989; 10(6):569-78. PubMed ID: 2481855
[TBL] [Abstract][Full Text] [Related]
18. Circulating and tissue concentrations of pregnancy-associated plasma protein-A (PAPP-A) in tubal ectopic gestation.
Sinosich MJ; Ferrier A; Teisner B; Porter R; Westergaard JG; Saunders DM; Grudzinskas JG
Clin Reprod Fertil; 1985 Dec; 3(4):311-7. PubMed ID: 2420432
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of eosinophil granule major basic protein in pregnant cynomolgus monkeys.
Wasmoen TL; Wagner JM; Bartemes KR; Gleich GJ
Placenta; 1992; 13(3):265-72. PubMed ID: 1635912
[TBL] [Abstract][Full Text] [Related]
20. Anti-progesterones: background and clinical physiology.
Cameron IT; Healy DL
Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):597-607. PubMed ID: 3069264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
